Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients

AIM: The study was aimed to understand the underlying causes for the differences in propranolol pharmacokinetics (PK) between healthy and cirrhosis populations by using a systematic whole-body physiologically based pharmacokinetic (PBPK) model-building approach for suggesting model informed proprano...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Des Devel Ther
Prif Awduron: Kalam, Muhammad Nasir, Rasool, Muhammad Fawad, Alqahtani, Faleh, Imran, Imran, Rehman, Asim Ur, Ahmed, Naveed
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7982780/
https://ncbi.nlm.nih.gov/pubmed/33762817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S297981
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg